Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What strategies can be implemented to increase inpefa's market share?Can lipitor interact with certain herbal remedies?Dupixent asthma reviews?What is sapropterin's role in cofactor creation?Cosentyx side effects weight loss?
See the DrugPatentWatch profile for emend
Emend (fosaprepitant or aprepitant) prevents nausea and vomiting from moderately or highly emetogenic chemotherapy, typically combined with ondansetron and dexamethasone. The regimen requires 3 doses over 3 days for adults and pediatric patients (age 6 months+), administered around highly emetogenic chemo like cisplatin or anthracyclines.[1][2]
Pediatric dosing (12+ years or 6 months+ based on weight): Same 3-dose structure, scaled by body surface area (e.g., Day 1: 3 mg/kg IV up to 115 mg). Reduce dexamethasone on Days 2-4 if using Emend to avoid steroid excess. Hepatic impairment usually needs no change; avoid in severe cases.[2][4]
For moderately emetogenic chemo, a single-day IV regimen (115 mg fosaprepitant on Day 1) may suffice without Days 2-3, per guidelines. Always follow oncologist's plan or label.[1][5]
Patients often ask about forgetting doses—take as soon as remembered, but don't double up. Side effects like fatigue or hiccups affect ~10-20%; report severe ones. Cost per 3-dose course: $500-800 without insurance.[3][6] Sources [1]: Emend Prescribing Information (Merck) [2]: FDA Label for Fosaprepitant [3]: ASCO Chemo Antiemetic Guidelines [4]: Micromedex Dosing [5]: NCCN Antiemesis Guidelines [6]: Drugs.com Pricing
Other Questions About Emend :